Safer Way of Stimulating Neural Stem Cells for Therapies and Research Developed

A new device that can increase the production of viable neural stem cells may change the landscape of neural stem cell therapies as potential strategies for neurodegenerative and chronic diseases, including Parkinson’s and Alzheimer’s. The invention, developed by a team at Hong Kong Baptist University (HKBU), was recently awarded with the Gold Medal with Congratulations of

FDA Grants Regenerative Medicine Advanced Therapy Designation to VY-AADC for Parkinson’s

The U.S. Food and Drug Administration granted Voyager Therapeutics’ gene therapy candidate VY-AADC regenerative medicine advanced therapy (RMAT) designation for the treatment of therapy-resistant motor fluctuations in Parkinson’s patients. The RMAT designation, recently created by the FDA, is given to regenerative medicine products intended to treat, modify, reverse, or cure a serious or life-threatening disease or

The ABCs of Parkinson’s Disease: The Letter B

Second in a series. Read part one. The letter B is for balance and Botox. Balance Many people with Parkinson’s experience walking or balance problems, which can occur in differing degrees. Gait problems can range from the disease slowing your speed, to a lessening of your arm swing and steps that tend to mimic shuffling

Dopamine Agonists Linked to Impulse Control Disorders in Parkinson’s Patients, Study Finds

More than half of Parkinson’s patients who have been treated with a dopamine agonist may develop impulse control disorders over time, according to recent research. The study, “Longitudinal analysis of impulse control disorders in Parkinson disease,” was published in the journal Neurology. Impulse control disorders are characterized by the inability to resist impulses or to control

Michael J. Fox Foundation Summit Outlines Next Steps in Search for Parkinson’s Cure

The Michael J. Fox Foundation (MJFF) recently held a summit to discuss the unmet needs and challenges for advancing therapies to slow down or halt Parkinson’s disease. The event, which took place in New York, was attended by representatives from 20 companies, a number of academic centers and research organizations, and the U.S. Food and Drug Administration. Some

New Tool Effectively Monitors Sleep Quality in Parkinson’s Patients, Researchers Say

A new tool called cardiopulmonary coupling could be used to effectively evaluate sleep quality in Parkinson’s disease patients, who often experience sleep disorders, according to a study. The study, “Assessment of sleep quality using cardiopulmonary coupling analysis in patients with Parkinson’s disease,” was published in Brain and Behavior. Disturbances in sleep — such as insomnia, sleep apnea,

Collaborative Project Will Target Gut Metabolites Involved in Parkinson’s

The Parkinson’s Institute and Clinical Center (PICC) and Axial Biotherapeutics have launched a partnership to develop interventions targeting gastrointestinal metabolites that may fuel the development of Parkinson’s disease. Previous work by Axial’s scientific co-founder Sarkis Mazmanian, PhD, has shown that the human gut microbiome — the natural collection of microorganisms living in our guts — can